Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
-
121
-
122
-
123
-
124
-
125
-
126
Decreased miR-24 sensitizes cells to apoptotic stimuli, and increases pro-apoptotic protein expression.
Published 2013“…<b>A</b>) 32Dcl3 and knockdown cells were washed out of 10 ng/ml IL-3 containing media. …”
-
127
<i>USP28</i> protein level was decreased by hypoxia signaling via both protein degradation and transcriptional repression in A549 cells.
Published 2013“…<p>(A) A549 cells were transfected with non-coding control siRNA or siRNA targeting human <i>HIF-1α</i> and <i>HIF-2α</i> (<i>HIF-1α</i> RNAi and <i>HIF-2α</i> RNAi mixture) for 48 hr, and then were treated with 1.0 mM NiSO<sub>4</sub> or cultured in 1% O<sub>2</sub> (Hy) for another 24 hr. …”
-
128
-
129
-
130
-
131
-
132
-
133
Beta-catenin signaling is decreased in intermediate progenitor cells.
Published 2010“…<p>(<b>A</b>) Cortex from E14.5 Axin2-d2EGFP transgenic mice stained for GFP (green), Tbr2 (red), and DNA (blue). …”
-
134
-
135
-
136
-
137
-
138
VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival.
Published 2018“…VRK1 score was determined by multiplying the VRK1 staining intensity × percentage of VRK1 positive staining. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0203397#pone.0203397.g008" target="_blank">Fig 8A</a> includes the data from all primary tumor and lymph node samples. …”
-
139
-
140